(Q39342992)

English

Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study

scientific article published on November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study (English)

1 reference

Europe PubMed Central

11 September 2017

1 reference

based on heuristic

inferred from title

Carmine Tinelli

9

1 reference

Europe PubMed Central

11 September 2017

Eugenia Quiros-Roldan

4

object named as

Eugenia Quiros Roldan

0 references

author name string

Andrea Patroni

1

1 reference

Europe PubMed Central

11 September 2017

Carlo Torti

2

1 reference

Europe PubMed Central

11 September 2017

Lina Tomasoni

3

1 reference

Europe PubMed Central

11 September 2017

Eugenia Quiros Roldan

4

1 reference

Europe PubMed Central

11 September 2017

Davide Bertelli

5

1 reference

Europe PubMed Central

11 September 2017

Massimo Puoti

6

1 reference

Europe PubMed Central

11 September 2017

Gian Pietro Cadeo

7

1 reference

Europe PubMed Central

11 September 2017

Intissar Sleiman

8

1 reference

Europe PubMed Central

11 September 2017

Giampiero Carosi

10

1 reference

Europe PubMed Central

11 September 2017

Francesco Castelli

11

1 reference

Europe PubMed Central

11 September 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

11 September 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

11 September 2017

3

1 reference

Europe PubMed Central

11 September 2017

6

1 reference

Europe PubMed Central

11 September 2017

451-461

1 reference

Europe PubMed Central

11 September 2017

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

The metabolic toxicities of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Lipodystrophy in patients naive to HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Lipodystrophy associated with nevirapine-containing antiretroviral therapies.

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy.

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Blood lipids of patients with chronic hepatitis: differences related to viral etiology.

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Metabolic Response to Infection

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FW024-QC4T-NXU0-TKYT

21 January 2018

Identifiers

10.1310/W024-QC4T-NXU0-TKYT

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39342992&oldid=2099970891"